Mark Marex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The biotechnology industry is a bifurcated space.

The Biotech Trek: A Short History from 1993 to 2021 June 29, 2021 The Nasdaq Biotechnology Index (NBI) launched in 1993, when the industry was still in the midst of the original “biotech revolution.” Since then, its constituent basket has swelled from roughly 100 components to 274, reflecting the tremendous growth in the small cap space – the overwhelming majority of which has stemmed from IPOs on the Nasdaq Stock Exchange. As the biotech industry enters a new phase of growth, it’s more important than ever for investors to consider their allocations toward the space. In the upcoming...

When it comes to biotechnology benchmarks, the Nasdaq Biotechnology Index (NBI) has set the standard.

The PHLX SOX Semiconductor Sector Index (SOX) – the most widely observed chip equity benchmark – has a new home among U.S.-listed exchange traded funds.

Those shortfalls are, in large part, attributable to a rapidly evolving technology landscape, one that includes technologies like data centers, electric vehicles, and much more. That bodes well for SOXX’s long-term trajectory. SOXX seeks to track the investment results of the PHLX Semiconductor Sector Index (SOX), which is composed of U.S. equities in the semiconductor sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of ...